Biocon’s biosimilar biz tops $4 bn in valuation Abu Dhabi-based sovereign wealth fund ADQ has picked up 1.80% stake in Biocon Biologics for $75 million; The company already raised $255 million from global marquee investors last year. By Anshul Dhamija
